Basic Information
| LncRNA/CircRNA Name | CARLo-5 |
| Synonyms | CCAT1, CARLo-5, onco-lncRNA-40 |
| Region | GRCh38_8:127207382-127219268 |
| Ensemble | ENSG00000247844 |
| Refseq | NR_108049 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | gastric cancer |
| ICD-0-3 | C16 |
| Methods | qPCR etc. |
| Sample | gastric cancer tissues |
| Expression Pattern | up-regulated |
| Function Description | We observed that the relative expression of CARLo-5 in gastric cancer tissues was significantly higher than that of their matched adjacent normal tissues. High CARLo-5 expression was found to be closely correlated with advanced T stage, positive distant metastasis, lymph node involvement, and poor differentiation. |
| Pubmed ID | 28239816 |
| Year | 2017 |
| Title | Long non-coding RNA CARLo-5 upregulation associates with poor prognosis in patients suffering gastric cancer. |
External Links
| Links for CARLo-5 | GenBank HGNC NONCODE |
| Links for gastric cancer | OMIM COSMIC |